Targeting α4 Integrin Containing Complexes in Multiple Myeloma Using Peptidomimetics
In our previous work we demonstrated that the integrin antagonist, HYD1, induced necrotic cell death in myeloma cell lines in vitro and in vivo as a single agent. In order to further delineate biomarkers of response to HYD1 we developed an isogenic drug resistant variant named H929-60. We show tha...
Main Author: | Emmons, Michael Foster |
---|---|
Format: | Others |
Published: |
Scholar Commons
2012
|
Subjects: | |
Online Access: | http://scholarcommons.usf.edu/etd/4314 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=5510&context=etd |
Similar Items
-
CD44 containing complexes as a therapeutic target in Multiple Myeloma
by: Gebhard, Anthony
Published: (2013) -
Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM)
by: Yuejiao Huang, et al.
Published: (2019-12-01) -
Adaptive Immunity and Pathogenesis of Diabetes: Insights Provided by the α4–Integrin Deficient NOD Mouse
by: Salim Oulghazi, et al.
Published: (2020-12-01) -
Functional Mapping of Adhesiveness on Live Cells Reveals How Guidance Phenotypes Can Emerge From Complex Spatiotemporal Integrin Regulation
by: Philippe Robert, et al.
Published: (2021-04-01) -
Dissecting Integrin Expression and Function on Memory B Cells in Mice and Humans in Autoimmunity
by: Alessandro Camponeschi, et al.
Published: (2019-03-01)